ABSTRACT
The major metabolite from the use of furazolidone (FZD) in mammals, birds and fish is 2,3-dihydro-3-cyanomethyl-2-hydroxy-5-nitro-1alpha, 2-di(2-oxo-oxazolidin-3-yl)iminomethyl-furo[2,3-β]furan, also called 3-amine-2-oxazolidone (AOZ). A minor metabolite was identified as N-(5-amine-2-furfuryliden)-3-amine-2-oxazolidone (FOZ). To assess the potential carcinogenicity of FZD and the metabolic mixture of AOZ/FOZ, 11 mg FZD/kg feed/day was fed for 12 weeks to mollies (Poecilia formosa), an ornamental fish species prone to develop tumors. The rate of tumors was quantified and defined both in mollies and their offspring. Then, some fish was made into fishmeal and incorporated into fish food at 500 g of meal/kg of food and fed to other mollies for 12 weeks. The rate of tumors was assessed. A similar trial design was carried out in tilapia fish (Oreochromis niloticus) by adding 50 mg FZD/kg to the feed for 90 days. All animals were placed in glass fishponds under controlled laboratory conditions. Each week, a significant biomass was collected from both groups to assess the macroscopic and histopathological changes. All mollies developed melanohistiocytomic tumors in the liver and other organs. Offspring from surviving mollie females stimulated to breed showed no changes compared to control animals. None of the mollies fed with the mollie-meal food contaminated with AOZ/FOZ developed tumors. Neither tilapia medicated with FZD nor tilapia fed with tilapia-meal contaminated with AOZ/FOZ developed tumors. These results do not support the established viewpoint that FZD must be banned from trophic chains based on its potential carcinogenic properties.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Morris JE, Price JM, Lalich JJ, Stein RJ . The carcinogenic activity of some 5-nitrofuran derivatives in the rat. Cancer Res 1969; 29: 2145–2156.
Ali BH . Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research. Vet Res Commun 1999; 23: 343–360.
Hernandez-Jauregui P, Revilla-Monsalve C, Velasco-Monterrubio E . Effects of furazolidone treatment on the morphology of rooster testicle. Light and electron microscopy study. Arch Investig Med 1983; 14: 1–8.
Salmon RJ, Buisson JP, Zafrani B, Aussepe L, Royer R . Carcinogenic effect of 7-methoxy-2-nitro-naphtho [2,1-b] furan (R 7000) in the forestomach of rats. Carcinogenesis 1986; 7: 1447–1450.
Tatsumi K, Takahashi Y . Metabolic fate of furazolidone in rats. Chem Pharm Bull Tokyo 1982; 30: 3435–3438.
Tatsumi K, Yamada H, Yoshimura H, Kawazoe Y . Metabolism of furazolidone by milk xanthine oxidase and rat liver 9000 g supernatant: formation of a unique nitrofuran metabolite and an aminofuran derivative. Arch Biochem Biophys 1981; 208: 167–174.
Stegeman JJ, Woodin BR, Singh H, Oleksiak MF, Celander M . Cytochromes P450 (CYP) in tropical fishes: catalytic activities, expression of multiple CYP proteins and high levels of microsomal P450 in liver of fishes from Bermuda. Comp Biochem Physiol Part C Pharmacol Toxicol Endocrinol 1997; 116: 61–75.
Bolis CL, Piccolella M, Dalla-Valle AZ, Rankin JC . Fish as model in pharmacological and biological research. Pharmacol Res 2001; 44: 265–280.
Woodhead AD, Setlow RB, Pond V . The amazon molly Poecilia formoza, as a test animal in carcinogenicity studies chronic exposure to physical agents. Natl Cancer Inst Monogr 1984; 65: 45–52.
Schartl A, Hornung U, Nanda I, Wacker R, Muller-Hermelink HK, Schlupp I et al. Susceptibility to the development of pigment cell tumors in a clone of the Amazon molly, Poecilia formosa, introduced through a microchromosome. Cancer Res 1997; 57: 2993–3000.
Bunton TE . Experimental chemical carcinogenesis in fish. Toxicol Pathol 1996; 24: 603–618.
Law JM . Issues related to the use of fish models in toxicology pathology: session introduction. Toxicol Pathol 2003: 49–52.
Scharti M, Schlupp I, Scharti A, Meyer MK, Nanda I, Schmid M et al. On the stability of dispensable constituents of the eukaryotic genome: stability of coding sequences versus truly hypervariable sequences in clonal vertebrate, the amazon molly, Poecilia formosa. Proc Natl Acad Sci USA 1991; 88: 8759–8763.
Zimmerer EJ . Usefulness of the guppy, Poecilia reticulata, in carcinogenicity testing: special advantages and problems. Natl Cancer Inst Monogr 1984; 65: 59–64.
Simon K, Lapis K . Carcinogenesis studies on guppies. Natl Cancer Inst Monogr 1984; 65: 71–81.
Conneely A, Nurgent A, O'Keeffe M . Use of solid phase extraction for the isolation and clean-up of derived furazolidone metabolite from animal tissues. Analyst 2002; 127: 705–709.
Pal AK, Rahman MS, Chatterjee SN . On the induction of umu gene expression in Salmonella typhimurium strain TA1535/pSK1002 by some nitrofurans. Mutat Res 1992; 280: 67–71.
Gajewska J, Szczypka M, Tudek B, Szymczyk T . Studies on the effect of ascorbic acid and selenium on the genotoxicity of nitrofurans: nitrofurazone and furazolidone. Mutat Res 1990; 232: 191–197.
Hoogenboom LAP, Berghmans MCJ, Polman THG, Parker R, Shaw IC . Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney and muscle tissues from pigs. In: Gilbert J. and Phillips T. Food Additives & Contaminants, Vol 9 Taylor & Francis: London 1992; pp 623–630.
Vroomen LH, Berghmans MC, Hekman P, Hoogenboom LA, Kuiper HA . The elimination of furazolidone and its open-chain cyano-derivative from adult swine. Xenobiotica 1987; 17: 1427–1435.
Klee S, Baumung I, Kluge K, Ungemach FR, Horne E, O'Keeffe M et al. A contribution to safety assessment of veterinary drug residues: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues. Xenobiotica 1999; 29: 641–654.
Hepher B Nutrición de peces comerciales en estanques. Limusa: México City 1998.
Ferguson HW Systemic Pathology of Fish. Iowa State University Press: Ames Iowa 1995.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Auro, A., Sumano, H., Ocampo, L. et al. Evaluation of the carcinogenic effects of furazolidone and its metabolites in two fish species. Pharmacogenomics J 4, 24–28 (2004). https://doi.org/10.1038/sj.tpj.6500216
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500216
Keywords
This article is cited by
-
Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics
Antimicrobial Resistance & Infection Control (2019)
-
A multiplex immunochromatographic test using gold nanoparticles for the rapid and simultaneous detection of four nitrofuran metabolites in fish samples
Analytical and Bioanalytical Chemistry (2018)
-
A fluorescent immunochromatographic strip test using a quantum dot-antibody probe for rapid and quantitative detection of 1-aminohydantoin in edible animal tissues
Analytical and Bioanalytical Chemistry (2018)
-
Lateral flow biosensor for multiplex detection of nitrofuran metabolites based on functionalized magnetic beads
Analytical and Bioanalytical Chemistry (2016)